These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34952210)

  • 1. Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.
    Riebensahm C; Chitundu H; Muula G; Chihota B; Sinkala E; Sunkutu V; Maurer MH; Dufour JF; Berzigotti A; Egger M; Bolton-Moore C; Vinikoor M; Wandeler G;
    Int J Infect Dis; 2022 Mar; 116():391-396. PubMed ID: 34952210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia.
    Vinikoor MJ; Hamusonde K; Muula G; Asombang M; Riebensahm C; Chitundu H; Sunkuntu-Sichizya V; Bhattacharya D; Sinkala E; Lauer G; Chung R; Mbewe W; Egger M; Bosomprah S; Wandeler G
    Clin Infect Dis; 2024 Jun; 78(6):1583-1590. PubMed ID: 37997691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
    Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
    Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
    Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
    Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
    Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
    Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
    Patel N; Post FA
    Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
    Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
    J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.
    Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ
    AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
    Surial B; Ramírez Mena A; Roumet M; Limacher A; Smit C; Leleux O; Mocroft A; van der Valk M; Bonnet F; Peters L; Rockstroh JK; Günthard HF; Berzigotti A; Rauch A; Wandeler G; ; ; ;
    J Hepatol; 2023 May; 78(5):947-957. PubMed ID: 36690280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
    Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
    Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
    Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
    Wandeler G; Musukuma K; Zürcher S; Vinikoor MJ; Llenas-García J; Aly MM; Mulenga L; Chi BH; Ehmer J; Hobbins MA; Bolton-Moore C; Hoffmann CJ; Egger M;
    PLoS One; 2016; 11(3):e0152043. PubMed ID: 27032097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
    Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
    Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda.
    Ocama P; Opio KC; Kagimu M; Seremba E; Wabinga H; Colebunders R
    Afr Health Sci; 2011 Aug; 11 Suppl 1(Suppl 1):S20-3. PubMed ID: 22135639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.
    Stockdale AJ; Phillips RO; Beloukas A; Appiah LT; Chadwick D; Bhagani S; Bonnett L; Sarfo FS; Dusheiko G; Geretti AM;
    Clin Infect Dis; 2015 Sep; 61(6):883-91. PubMed ID: 26021992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Threat: HDV, HBV, HIV Coinfection.
    Yen DW; Soriano V; Barreiro P; Sherman KE
    Clin Liver Dis; 2023 Nov; 27(4):955-972. PubMed ID: 37778779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.